CG Oncology, Inc. Common stockCGONNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-78.95M
↓ 88% below average
Average (3y)
$-42.05M
Historical baseline
Range
High:$-13.75M
Low:$-78.95M
CAGR
+79.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-78.95M | -72.8% |
| 2023 | $-45.68M | -53.2% |
| 2022 | $-29.82M | -116.8% |
| 2021 | $-13.75M | - |